Merck pulling Vioxx from the market

MRK was down $12.07 (27%) to $33 on 145 million shares on Thursday after announcing that it will withdraw its Vioxx rofecoxib COX-2 inhibitor from markets worldwide. The decision relates to data

Read the full 322 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE